Improving access to targeted therapies for gynecologic cancer patients
Official title: Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations
Funded at Ohio State University · NIH-10782742 · Data updated 2026-11-12
This study is all about helping more people with gynecologic cancers, especially endometrial cancer, find the right treatments by matching them with targeted therapies based on their unique cancer profiles, while also making sure that everyone, especially those from underrepresented groups, has a fair chance to join clinical trials and get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | September 11, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $132,015 |
| NIH project number | 1R50CA287196-01 |
| Project ID | NIH-10782742 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients diagnosed with endometrial cancer, especially those from minority groups who may have high-risk subtypes.
✕Less likely to help
Patients with gynecologic cancers who do not have access to clinical trials or those who do not fit the molecular profiles being studied may not benefit from this research.
What this research studies
This research focuses on enhancing clinical trial enrollment for gynecologic cancers, particularly endometrial cancer, by utilizing molecular matching to identify suitable targeted therapies. It aims to address the disparities in access to care for underrepresented populations, who often face higher risks and unique subtypes of these cancers. The approach involves increasing awareness and participation in clinical trials among these groups, thereby improving the chances of receiving effective treatments. The study will leverage recent advancements in molecular profiling to ensure that patients are matched with the most appropriate therapies.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better treatment outcomes for patients with gynecologic cancers, particularly those from underrepresented populations.
How similar studies have gone: Other research has shown success in improving clinical trial enrollment through targeted approaches, indicating that this methodology has potential for positive outcomes.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Backes, Floor J. — Ohio State University
- Study coordinator: Backes, Floor J.
Related research
Other NIH-funded projects on the same topics.
-
Standardized, patient-centered treatment plans for breast and gynecologic cancer survivors facing sexual dysfunction and vaginal microbiome changes
A patient-friendly program tests personalized, non-hormonal treatment plans for sexual dysfunction in breast cancer survivors, guided by changes in the vaginal microbiome.
-
Gynecologic cancer care: faster enrollment in targeted trials through molecular matching and better access to care
Aims to speed up enrollment in personalized gynecologic cancer trials by matching patients to targeted therapies and improving access to care.
-
WNT4 and gynecologic cancer: a genetic link to therapy resistance and disparities
Researchers are studying how a gene variant called WNT4 may influence gynecologic cancers and contribute to differences in risk among populations, with the aim of improving future treatments.
-
Virtual Mindful After Cancer program to improve sexual health for breast and gynecologic cancer survivors
A web-based mindfulness program is being tested to help breast and gynecologic cancer survivors who have sexual health concerns.
-
Promoting open talks about sexual health after gynecologic cancer
A patient-focused program helps women with gynecologic cancer start and guide conversations about sexual health with their doctors.
-
Modernizing Gynecologic Cancer Trial Rules to Enroll More Patients
Aims to make gynecologic cancer clinical trials more accessible to diverse patients so more people can benefit from new treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.